The Virtual Oncology Market is estimated at US$5.4 billion in 2026 and is projected to grow at a CAGR of 18.8% to reach US$21.4 billion by 2034.
Core applications include remote oncology consultations, symptom management, treatment navigation, survivorship support, second opinions, and multidisciplinary coordination across cancer care pathways. Demand reflects the need for convenient access to oncology expertise, pressure to reduce travel burden, growth in telehealth acceptance, and demand for better.
This product will be delivered within 1-3 business days.
Market Overview
The Virtual Oncology Market covers digital oncology care platforms and remote service models that support consultation, navigation, symptom monitoring, education, and coordination for cancer patients and care teams. Its value chain includes telehealth platforms, oncology providers, diagnostic partners, care navigators, payers, software vendors, and patient support services.Core applications include remote oncology consultations, symptom management, treatment navigation, survivorship support, second opinions, and multidisciplinary coordination across cancer care pathways. Demand reflects the need for convenient access to oncology expertise, pressure to reduce travel burden, growth in telehealth acceptance, and demand for better.
Key Companies Analysed
- Teladoc Health
- Amwell
- City of Hope
- Mayo Clinic
- Memorial Sloan Kettering
- MD Anderson Cancer Center
- Mass General Brigham
- Cleveland Clinic
- Flatiron Health
- Accolade
- OncoHealth
- Included Health
- Navigating Cancer
- Canopy
- Thyme Care
- Color Health
- Guardant Health
- Tempus
- Mytonomy
- Epic Systems
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Virtual Oncology Market Overview
3. Virtual Oncology Market Dynamics
4. Virtual Oncology Market Strategic Analysis
5. Global Virtual Oncology Market Size, Share and Forecast, 2025-2034
6. North America Virtual Oncology Market Outlook to 2034
7. Europe Virtual Oncology Market Outlook to 2034
8. Asia-Pacific Virtual Oncology Market Outlook to 2034
9. Middle East and Africa Virtual Oncology Market Outlook to 2034
10. South and Central America Virtual Oncology Market Outlook to 2034
11. Virtual Oncology Market Competitive Landscape
12. Appendix
Companies Mentioned
- Teladoc Health
- Amwell
- City of Hope
- Mayo Clinic
- Memorial Sloan Kettering
- MD Anderson Cancer Center
- Mass General Brigham
- Cleveland Clinic
- Flatiron Health
- Accolade
- OncoHealth
- Included Health
- Navigating Cancer
- Canopy
- Thyme Care
- Color Health
- Guardant Health
- Tempus
- Mytonomy
- Epic Systems
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 5.4 Billion |
| Forecasted Market Value ( USD | $ 21.4 Billion |
| Compound Annual Growth Rate | 18.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
